Merck's Keytruda meets main goal in late-stage breast cancer study
Merck (MRK.N) said on Friday its blockbuster drug Keytruda, in combination with chemotherapy, met one of the main goals in a late-stage...
Harvard Scientists Uncover Long-Missing Piece in Breast Cancer Puzzle
In what may turn out to be a long-missing piece in the puzzle of breast cancer, Harvard Medical School researchers have identified the...
Most People With Early Stage Breast Cancer Will Be Long-Term Survivors: Study
There’s some good news as it relates to breast cancer—the most common type of cancer in women after skin cancer.1 New research shows that...
Dana-Farber doctor explains change to breast cancer screening guidelines
When the guidelines for breast cancer screening changed last month, many American women sat up and took notice. The U.S. Preventative...
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Novartis (NOVN.S) breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial on women diagnosed at an...
Artificial intelligence model to help scientists predict whether breast cancer will spread
Oncologists in the UK have developed an AI model to help predict whether aggressive forms of breast cancer will spread based on changes...
Why are breast cancer screening guidelines so confusing? Here’s what you need to know
The U.S. Preventive Services Task Force just released new draft guidelines on breast cancer prevention, and they're stirring up some...
Researchers Identify Possible New Risk for Breast Cancer
Scientists have long known that dense breast tissue is linked to an increased risk of breast cancer in women. A study published on...
Ohio woman, the first person to receive a breast cancer vaccine in trial, awaits results
While a breast cancer vaccine is not yet approved for widespread use, there are trials underway — including one at Cleveland Clinic,...
Genetic differences in breast tumors may contribute to racial disparities
Clinicians know the odds tend to be stacked against Black breast cancer patients. They have more dangerous and aggressive subtypes of...
